Hemolytic uremic syndrome

Seminars in Thrombosis and Hemostasis

Volumn 36, Issue 6, 2010, Pages 573-574

  Favaloro, Emmanuel J ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ACUTE KIDNEY FAILURE; CELL DAMAGE; CLINICAL FEATURE; EDITORIAL; ENDOTHELIUM CELL; ENTEROHEMORRHAGIC ESCHERICHIA COLI; HEMOLYTIC UREMIC SYNDROME; MICROCIRCULATION; MUTATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; THROMBOGENESIS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

COMPLEMENT SYSTEM PROTEINS; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HEMOLYTIC-UREMIC SYNDROME; HOST-PATHOGEN INTERACTIONS; HUMANS; MUTATION;

EID: 77957581427     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0030-1262878     Document Type: Editorial

References (20)

1. Franchini M, Montagnana M, Targher G, Lippi G. Reduced von Willebrand factor-cleaving protease levels in secondary thrombotic microangiopathies and other diseases. Semin Thromb Hemost 2007 33 (8) 787-797
2. Zhou Z, Nguyen T C., Guchhait P, Dong J F. Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura. Semin Thromb Hemost 2010 36 (1) 71-81
3. Mammen E F. Thrombotic microangiopathies. Semin Thromb Hemost 2006 32 (2) 79-80
4. Prüfer F, Scheiring J, Sautter S et al. Terminal complement complex (C5b-9) in children with recurrent hemolytic uremic syndrome. Semin Thromb Hemost 2006 32 (2) 121-127
5. Gordjani N, Sutor A H., Zimmerhackl L B., Brandis M. Hemolytic uremic syndromes in childhood. Semin Thromb Hemost 1997 23 (3) 281-293
6. Sutor A H., Thomas K B., Prüfer F H., Grohmann A, Brandis M, Zimmerhackl L B. Function of von Willebrand factor in children with diarrhea-associated hemolytic-uremic syndrome (D+HUS). Semin Thromb Hemost 2001 27 (3) 287-292
7. Karch H, Friedrich A W., Gerber A, Zimmerhackl L B., Schmidt M A., Bielaszewska M. New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome. Semin Thromb Hemost 2006 32 (2) 105-112
8. Zimmerhackl L B., Besbas N, Jungraithmayr T et al, European Study Group for Haemolytic Uraemic Syndromes and Related Disorders. Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome. Semin Thromb Hemost 2006 32 (2) 113-120
9. Karpman D, Sartz L, Johnson S. Pathophysiology of typical hemolytic uremic syndrome. Semin Thromb Hemost 2010 36 (6) 575-585
10. Zimmerhackl L-B, Rosales A, Hofer J et al. Enterohemorrhagic Escherichia coli O26:H11-associated hemolytic uremic syndrome: bacteriology and clinical presentation. Semin Thromb Hemost 2010 36 (6) 586-593
11. Bitzan M, Schaefer F, Reymond D. Treatment of typical (enteropathic) hemolytic uremic syndrome. Semin Thromb Hemost 2010 36 (6) 594-610
12. Oppermann M, Würzner R. Modern determination of complement activation. Semin Thromb Hemost 2010 36 (6) 611-619
13. Orth D, Würzner R. Complement in typical HUS. Semin Thromb Hemost 2010 36 (6) 620-624
14. Skerka C, Zipfel P F., Müller D et al. The autoimmune disease DEAP HUS (hemolytic uremic syndrome). Semin Thromb Hemost 2010 36 (6) 625-632
15. Dragon-Durey M-A, Blanc C, Garnier A, Hofer J, Vester U, Zimmerhackl L-B. Anti-factor H auto-antibodies associated hemolytic uremic syndrome: review of literature of the auto-immune form of HUS. Semin Thromb Hemost 2010 36 (6) 633-640
16. Moglie L Q., Roumenina L, Noris M, Frémeaux-Bacchi V. Atypical hemolytic uremic syndrome associated with mutations in complement regulator genes. Semin Thromb Hemost 2010 36 (6) 641-652
17. Kavanagh D, Richards A, Goodship T, Jalanko H. Transplantation in atypical hemolytic uremic syndrome. Semin Thromb Hemost 2010 36 (6) 653-659
18. Emlen W, Li W, Kirschfink M. Therapeutic complement inhibition: new developments. Semin Thromb Hemost 2010 36 (6) 660-668
19. Köse ö, Jungraithmayr T, Zimmerhackl L-B, Mache C, Nürnberger J. New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab. Semin Thromb Hemost 2010 36 (6) 669-672
20. Loirat C, Garnier A, Sellier-Leclerc A-L, Kwon T. Plasmatherapy in atypical hemolytic uremic syndrome. Semin Thromb Hemost 2010 36 (6) 673-681